^M
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 10, 2000
VENTRO CORPORATION
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 0-26811 77-0465496
- ------------------------------- ------------------------ --------------------
(State or Other Jurisdiction of (Commission File Number) (IRS Employer
Incorporation or Organization) Identification No.)
1500 Plymouth Street
Mountain View, CA 94043
--------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
(650) 567-8900
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
N/A
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
================================================================================
<PAGE>
Registrant hereby files Amendment No. 2 to the Form 8-K initially filed on
February 10, 2000.
ITEM 7. Financial Statements and Exhibits.
(c) Exhibits
(23.1) Consent of Ernst & Young, Independent Auditors with respect
to financial statements of Promedix.com, Inc.
(23.2) Consent of Ernst & Young, Independent Auditors with respect
to financial statements of SpecialtyMD.com, Inc.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: May 24, 2000
VENTRO CORPORATION
By: /s/ Jim Stewart
------------------------------
Name: Jim Stewart
Title: Chief Financial Officer
EXHIBIT INDEX
Exhibit
No. Description
- ------- ------------------------------------------------------------------
23.1 Consent of Ernst & Young, Independent Auditors with respect to
financial statements of Promedix.com, Inc.
23.2 Consent of Ernst & Young, Independent Auditors with respect to
financial statements of SpecialtyMD.com, Inc.
CONSENT OF ERNST & YOUNG, LLP INDEPENDENT AUDITORS
We consent to the reference to our firm under the caption "Experts" in the
Registration Statement as amended (Form S-1 No. 33-31774) and related
Prospectus of Ventro Corporation for the registration of Convertible
Subordinated Notes due in 2007 with the principal amount of $345,000,000
and the registration of shares of common stock issuable upon conversion and
to the use of our report dated February 11, 2000 on the financial
statements of Promedix.com, Inc. included in the Registration Statement, as
amended (Form S-1) and the related Prospectus of Ventro Corporation
incorporated by reference in its Current Report on Form 8-K/A dated May 24,
2000, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Salt Lake City, Utah
May 23, 2000
CONSENT OF ERNST & YOUNG, LLP INDEPENDENT AUDITORS
We consent to the reference to our firm under the caption "Experts" in the
Registration Statement as amended (Form S-1 No. 33-31774) and related
Prospectus of Ventro Corporation for the registration of Convertible
Subordinated Notes due in 2007 with the principal amount of $345,000,000
and the registration of shares of common stock issuable upon conversion and
to the use of our report dated January 10, 2000 on the financial statements
of SpecialtyMD.com, Inc. included in the Registration Statement, as amended
(Form S-1) and the related Prospectus of Ventro Corporation incorporated by
reference in its Current Report on Form 8-K/A dated May 24, 2000, filed with
the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Palo Alto, California
May 23, 2000
